Abacus Bioscience logo

Abacus Bioscience

Sammamish, WA

Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease and oncology.

abacusbioscience.com

Company Details

Founded

2017

Employees

Between 2 - 10 employees

Raised

$4,413,591

Headquarters Location

Sammamish, WA

Public

No

Acquired

No

CEO

N/A

Company Collections

These are collections Abacus Bioscience is a part of. Click on the collection name to view similar companies.

Abacus Bioscience's Industries